ORAGENICS INC — Director's Dealing 2017

Jun 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN.BC)
CIK: 0001174940
Period of Report: 2017-06-22

Reporting Person: Sullivan Michael O'Keefe (CFO, Secretary and Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-22	Employee Stock Option (Right to Buy)	$0.37	A	175000	Acquired	2027-06-22	Common Stock (175000)	Direct

Footnotes

F1: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017.